Standardization of Spatial Neglect Assessment Tests

NCT ID: NCT07145970

Last Updated: 2026-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

210 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-07

Study Completion Date

2027-01-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spatial neglect is a common cognitive disorder in stroke patients, characterized by a lateralized deficit in attention and intention.

This research focuses on defining norms for tests to assess spatial neglect. The norms correspond to the results obtained in a population free of any disorder that could have an impact on test performance. These results can vary in a normal, non-pathological way, with certain parameters such as age, sex, laterality or level of education. Defining these norms in healthy volunteers is therefore essential for interpreting results in patients suspected of spatial neglect, and in particular for defining pathological thresholds above which the diagnosis of spatial neglect can be retained.

To answer the research question, we plan to include 210 people with no central neurological disease (stroke, epilepsy and multiple sclerosis in particular), in a single-center study in the neurovascular department of the Raymond-Poincaré hospital (Garches). The 210 subjects will be divided into 10-year age groups, from 20 to 89 years, with the recruitment of 30 participants per age group (15 men and 15 women): 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, 80-89 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spatial neglect is a loss of attention to stimuli in the absence of sensory damage. It is most often a left egocentric hemineglect, due to involvement of the right perisylvian cortex, in which the patient neglects stimuli to his left. More recently, allocentric neglect has been described, where the patient neglects the right or left part of each stimulus. Egocentric neglect is common in stroke patients and correlates with poorer functional recovery and degraded quality of life. The prevalence and impact of allocentric neglect on patients is less well known, not least because of a lack of assessment tools. Tests have recently been developed in English to screen simultaneously for allocentric and egocentric visual neglect. These tests are based on target cancellation, such as whole or open apples in the Apples cancellation test of the Birmingham Cognitive Screen. There is currently no validated French-language version of these tests.

In the case of personal, motor and tactile neglect, these three components are difficult to separate. A patient's ability to indicate blindly, by tactile exploration, the middle of a ruler, or to explore by touch different targets placed in front of him/her, should, after standardization, enable exploration of these last two types of neglect. A simplified version of the Comb and Razor Test should enable assessment of personal and motor neglect.

The aim of this study is to establish mean scores for healthy French-speaking volunteers without central neurological disease on different spatial neglect assessment tests according to their age, sex and level of professional qualification, using French-translated instructions for taking and scoring the tests.

Healthy volunteers with no known history of stroke or cognitive impairment will be included prospectively in the neurovascular department of the Raymond-Poincaré hospital in Garches. We aim to recruit 30 subjects (15 men and 15 women) in 10-year age groups (20 to 29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79 and 80 to 89), i.e. 210 subjects.

The significance threshold will be defined at 0.05. Statistical analyses will be performed using Rstudio software.

Qualitative variables will be described by their numbers and percentages, and quantitative variables by their means, standard deviations, minimums, maximums, as well as their medians and interquartile ranges (25th percentile - 75th percentile).

To identify the association between the variables (age, gender, level of qualification and laterality) and the metrics relating to the results of the following tests (Apples cancellation test, Comb and razor test, Peg test and Ruler blind bisection test) and their completion times, a linear regression will be conducted. The variables to be explained will be the metrics relating to the results of the following tests (Apple test, Comb and razor test, Plot test and Ruler bisection test) and their completion times. Explanatory variables will be age, gender, level of qualification, hand used and laterality.

If no significant association is found between the explanatory variables and the metrics relating to test results and completion times, a mean score with its 95% confidence interval will be estimated.

If there is a significant association between the explanatory variables and the metrics relating to the test results and their completion times, taking into account the characteristics of the healthy volunteers, a mean score for the metrics associated with its 95% confidence interval will be estimated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perceptual Disorders Healthy Volunteers Reference Values

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group

Group Type EXPERIMENTAL

Neuropsychological assessment tests for spatial neglect

Intervention Type OTHER

Standardized administration of four paper-and-pencil tests designed to assess different forms of spatial neglect:

* Apples Cancellation Test (Birmingham Cognitive Screen) for egocentric and allocentric neglect,
* Simplified Comb and Razor Test for personal and motor neglect,
* Line Bisection Test (30 cm ruler, blind version) for tactile neglect,
* Dot Test for visual exploration.

The purpose is to establish normative reference scores in healthy French-speaking adults according to age, sex, and professional qualification. No therapeutic intervention or patient population is involved.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuropsychological assessment tests for spatial neglect

Standardized administration of four paper-and-pencil tests designed to assess different forms of spatial neglect:

* Apples Cancellation Test (Birmingham Cognitive Screen) for egocentric and allocentric neglect,
* Simplified Comb and Razor Test for personal and motor neglect,
* Line Bisection Test (30 cm ruler, blind version) for tactile neglect,
* Dot Test for visual exploration.

The purpose is to establish normative reference scores in healthy French-speaking adults according to age, sex, and professional qualification. No therapeutic intervention or patient population is involved.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy volunteer attending the neurovascular department of Raymond-Poincaré Hospital
2. Aged between 20 and 89 years
3. Affiliated with a health insurance scheme
4. French-speaking
5. Has freely and knowingly expressed their non-opposition

Exclusion Criteria

1. Known history of central neurological disease: stroke (ischemic or hemorrhagic), transient ischemic attack, encephalitis, multiple sclerosis, or epilepsy.
2. Medical interview suggesting past central nervous system involvement: history of episodes such as sensorimotor deficits, dysarthria, aphasia, blurred or double vision, or positive symptoms such as visual or sensory hallucinations (e.g., paresthesias).
3. Significant visual impairment - as judged by the examiner - in near vision despite correction, or monocular blindness. Specifically, inability to distinguish the targets with gaps in the example (pre-test) of the Apples Cancellation Test.
4. Abnormal neurological examination:

1. National Institutes of Health Stroke Scale (NIHSS) score \> 0
2. Pyramidal reflex syndrome (hyperactive deep tendon reflexes with extended reflexogenic zones and spread).
5. Use of substances (alcohol or drugs) within 24 hours prior to the assessment.
6. Presence of cognitive or psychiatric disorders, assessed during the inclusion interview and neurological examination, at the examiner's discretion.
7. Language barrier or aphasia, assessed during the inclusion interview and neurological examination, at the examiner's discretion.
8. Participant under legal protection (guardianship, curatorship, or legal safeguard).
Minimum Eligible Age

20 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Raymond Poincarré

Garche, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-Baptiste BRUNET de COURSSOU, Dr

Role: CONTACT

+33 1 47 10 72 55

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jean Baptiste BRUNET DE COURSSOU, PhD

Role: primary

147 10 44 68 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP250520

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neural Correlates of Intern Speech
NCT02830100 TERMINATED NA